Research studies have reported reduced expressions of adropin in metabolic syndrome, hyperlipidemia, obesity, and polycystic ovary syndrome, which are associated with inflammation. The gene discussed is ENHO; the disease is obesity due to melanocortin 4 receptor deficiency.